KStrategy&
LightNews LightNews
banner
kstrategyand.bsky.social
KStrategy&
@kstrategyand.bsky.social
17 followers 1 following 140 posts
KStrategy& develops digital solutions and helps #healthcare / #pharma companies maximize the value of their discoveries through research and consulting services
Posts Replies Media Videos
kstrategyand.bsky.social
Weekly Roundup - PHARMA - 10 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#Celltrion #Avtozma #Axsome #Symbravo #Anzupgo #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - PHARMA - 10 February 2025
🔊Celltrion’s Avtozma Wins FDA Approval for Autoimmune & Inflammatory Diseases Avtozma, an Actemra biosimilar, is approved in both IV and SC forms, backed by a Phase III trial confirming its similarity...
www.linkedin.com
February 12, 2025 at 4:22 AM
kstrategyand.bsky.social
Weekly Roundup - DIGITAL HEALTH/DTx - 11 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/digital-heal...

#HighmarkHealth #Stanza #DigitalHealth #HealthTech #Telemedicine #Telehealth #mHealth #HealthIT #eHealth #DigitalMedicine #DTx #MedTech #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - DIGITAL HEALTH/DTx - 11 February 2025
Highmark Health Expands Access to Stanza, FDA-Cleared Digital Therapy for Fibromyalgia Swing Therapeutics' digital treatment for fibromyalgia, Stanza, has received a positive coverage decision from Hi...
www.linkedin.com
February 12, 2025 at 4:07 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/uwa-re...

UWA Researchers Secure $3M to Drive AI-Powered Digital Health Innovations

kstrategyand.com/pharma-news

#UWA #DigitalHealth #AIHealthcare #PatientOutcomes #AudiologyTech #HealthTech #Humanteconomy #Humantec #KStrategyand
UWA Researchers Secure $3M to Drive AI-Powered Digital Health Innovations
The University of Western Australia (UWA) continues to solidify its reputation as a leader in digital health innovation, with eight of its researchers securing nearly $3 million in funding through the...
www.linkedin.com
February 12, 2025 at 3:50 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/gsk-ex...

GSK Expands Cancer Portfolio with $1.15B Acquisition of IDRx, Eyeing Breakthrough GIST Therapy

kstrategyand.com/pharma-news

#GSK #IDRx #GIST #CancerTreatment #CancerCare #HealthcareInnovation #MedicalBreakthrough #Humanteconomy #Humantec #KStrategyand
GSK Expands Cancer Portfolio with $1.15B Acquisition of IDRx, Eyeing Breakthrough GIST Therapy
GSK has struck a deal to acquire IDRx, Inc., a Boston-based clinical-stage biopharmaceutical company, for up to $1.
www.linkedin.com
February 12, 2025 at 3:40 AM
kstrategyand.bsky.social
Kairos Pharma Secures $3.5 Million in PIPE Financing to Accelerate Growth

www.linkedin.com/pulse/kairos...

kstrategyand.com/pharma-news

#KairosPharma #PIPEFinancing #CancerResearch #PharmaceuticalGrowth #CancerTherapeutics #InvestmentDeal #BiotechInnovation #Humanteconomy #Humantec #KStrategyand
Kairos Pharma Secures $3.5 Million in PIPE Financing to Accelerate Growth
Kairos Pharma, Ltd. (NYSE American: KAPA), a pharmaceutical company with a market cap of $22.
www.linkedin.com
February 5, 2025 at 7:25 AM
kstrategyand.bsky.social
Weekly Roundup - DIGITAL HEALTH/DTx - 4 February 2025

www.linkedin.com/pulse/weekly...

➡ kstrategyand.com/digital-heal...

#CareLoop #KAIST #UniversityOfMichigan #WHO #eHealth #DigitalMedicine #DTx #MedTech #Humanteconomy #Humantec #KStrategyand
February 5, 2025 at 3:51 AM
kstrategyand.bsky.social
🚀 Weekly Roundup - PHARMA - 3 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#AstraZeneca #Calquence #Eisai #Biogen #Leqembi #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - PHARMA - 3 February 2025
🔊AstraZeneca’s Calquence Wins FDA Approval as First-Line Treatment for Mantle Cell Lymphoma AstraZeneca’s Calquence (acalbrutinib) received FDA approval for first-line mantle cell lymphoma, showing a ...
www.linkedin.com
February 3, 2025 at 11:33 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/astraz...

AstraZeneca’s Calquence Gains Full Approval for Lymphoma, Faces Medicare Price Negotiations

kstrategyand.com/pharma-news

#AstraZeneca #Calquence #InflationReductionAct #BTKInhibitor #MedicalBreakthrough #CancerResearch #Humanteconomy #Humantec #KStrategyand
AstraZeneca’s Calquence Gains Full Approval for Lymphoma, Faces Medicare Price Negotiations
AstraZeneca has earned full FDA approval for its lymphoma treatment, Calquence, offering a significant step forward in the fight against mantle cell lymphoma (MCL). Originally granted accelerated appr...
www.linkedin.com
February 3, 2025 at 10:53 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/retro-...

Retro Biosciences and OpenAI Join Forces to Tackle Aging with $1 Billion Investment

kstrategyand.com/pharma-news

#RetroBiosciences #OpenAI #AlzheimersTreatment #FutureOfMedicine #LifeExtension #Healthspan #AIandBiotech #Humanteconomy #Humantec #KStrategyand
Retro Biosciences and OpenAI Join Forces to Tackle Aging with $1 Billion Investment
San Francisco-based Retro Biosciences, a biotech start-up with a bold vision to extend human life by a decade, is gearing up for a $1 billion funding round to accelerate its ambitious mission. Backed ...
www.linkedin.com
February 3, 2025 at 10:40 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/fda-ap...

FDA Approves Johnson & Johnson's SPRAVATO® as the First Monotherapy for Treatment-Resistant Depression in Adults

kstrategyand.com/pharma-news

#SPRAVATO #FDAApproval #TRD #NewHopeForDepression #BreakthroughTreatment #Humanteconomy #Humantec #KStrategyand
FDA Approves Johnson & Johnson's SPRAVATO® as the First Monotherapy for Treatment-Resistant Depression in Adults
Johnson & Johnson has just achieved a major breakthrough in the mental health space, with the approval of SPRAVATO® (esketamine) nasal spray as the first and only monotherapy for adults suffering from...
www.linkedin.com
January 31, 2025 at 10:41 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/fda-gr...

FDA Greenlights AstraZeneca and Daiichi Sankyo’s Datroway for Breast Cancer Treatment

kstrategyand.com/pharma-news

#AstraZeneca #DaiichiSankyo #HealthcareInnovation #ADCTherapy #TargetedTherapies #MedicalBreakthrough #CancerCare #Humanteconomy #Humantec
FDA Greenlights AstraZeneca and Daiichi Sankyo’s Datroway for Breast Cancer Treatment
AstraZeneca and Daiichi Sankyo have scored a significant win with the U.S.
www.linkedin.com
January 29, 2025 at 8:52 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/tuva-h...

Tuva Health’s Open-Source Approach to Healthcare Data Wins $5M in Seed Funding

kstrategyand.com/digital-heal...

#TuvaHealth #HealthcareAnalytics #HealthTech #EHR #HealthData #ClinicalResearch #TechForGood #DigitalHealth #Humanteconomy #Humantec #KStrategyand
Tuva Health’s Open-Source Approach to Healthcare Data Wins $5M in Seed Funding
Tuva Health, an open-source healthcare data transformation platform, has officially emerged from stealth with a $5 million seed round and a bold vision to revolutionize the healthcare analytics indust...
www.linkedin.com
January 29, 2025 at 8:44 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/soricl...

SoriClear by NewLive: South Korea’s Fifth Digital Therapeutic Targets Tinnitus

kstrategyand.com/digital-heal...

#NewLive #SoriCLEAR #DigitalTherapeutics #TinnitusTreatment #AIHealthcare #GlobalHealth #MedicalBreakthrough #Humanteconomy #Humantec #KStrategyand
SoriClear by NewLive: South Korea’s Fifth Digital Therapeutic Targets Tinnitus
NewLive, an innovative startup founded by Professor Sang Jae-jun of Korea University Guro Hospital, has recently made waves in the medical field with the approval of its tinnitus treatment tool, SoriC...
www.linkedin.com
January 29, 2025 at 8:33 AM
kstrategyand.bsky.social
Weekly Roundup - DIGITAL HEALTH/DTx - 28 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/digital-heal...

#NewLive #SoriCLEAR #CancerResearchUK #NIHR #EPSRC #Trinity #SUSA #DarioHealth #GLP1 #MediOrbis #KarolinskaInstitutet #NeurEYE #MedTech #Humanteconomy #Humantec #KStrategyand
January 28, 2025 at 10:28 AM
kstrategyand.bsky.social
🚀 Weekly Roundup - PHARMA - 27 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#AstraZeneca #Calquence #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec
Weekly Roundup - PHARMA - 27 January 2025
🔊AstraZeneca's Calquence Gets Full FDA Approval for Mantle Cell Lymphoma Calquence becomes the first BTK inhibitor approved for first-line treatment of mantle cell lymphoma, offering a 27% progression...
www.linkedin.com
January 27, 2025 at 10:58 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/new-er...

A New Era in Bladder Cancer Treatment: Pfizer’s Sasanlimab Hits the Mark

kstrategyand.com/pharma-news

#Pfizer #Sasanlimab #BCG #CancerResearch #BladderCancerAwareness #NewTreatment #PharmaceuticalInnovation #HealthCare #Humanteconomy #Humantec #KStrategyand
A New Era in Bladder Cancer Treatment: Pfizer’s Sasanlimab Hits the Mark
Pfizer has unveiled groundbreaking Phase 3 results for its investigational PD-1 inhibitor, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG), a long-standing standard of care for high-ris...
www.linkedin.com
January 27, 2025 at 4:44 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/lilly-...

Lilly Expands Inflammatory Bowel Disease Portfolio with FDA Nod for Omvoh® in Crohn's

#Omvoh #EliLilly #CrohnsDisease #IBD #MedicalBreakthrough #ChronicIllness #Inflammation #PatientCare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
Lilly Expands Inflammatory Bowel Disease Portfolio with FDA Nod for Omvoh® in Crohn's
Eli Lilly’s Omvoh® (mirikizumab-mrkz) has gained a significant regulatory nod, securing FDA approval for the treatment of moderately to severely active Crohn’s disease in adults. This marks a pivotal ...
www.linkedin.com
January 27, 2025 at 4:34 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/karoli...

Karolinska Institute’s Digital Physiotherapy App Transforms Stroke Recovery with Nationwide Impact

kstrategyand.com/pharma-news

#StrokeRecovery #DigitalPhysiotherapy #StrokeSurvivors #PhysiotherapyApp #SwedenHealthcare #Humanteconomy #Humantec #KStrategyand
Karolinska Institute’s Digital Physiotherapy App Transforms Stroke Recovery with Nationwide Impact
A breakthrough study from Karolinska Institute is redefining stroke rehabilitation by introducing a fully digital approach to physiotherapy that has proven highly effective and widely accessible. Publ...
www.linkedin.com
January 24, 2025 at 9:54 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/tyra-b...

Tyra Biosciences Advances TYRA-300 to Phase 2 Trial for Bladder Cancer Treatment

kstrategyand.com/pharma-news

#TyraBiosciences #TYRA300 #BladderCancer #CancerResearch #InnovationInMedicine #BladderCancerAwareness #Humanteconomy #Humantec #KStrategyand
Tyra Biosciences Advances TYRA-300 to Phase 2 Trial for Bladder Cancer Treatment
Tyra Biosciences, a cutting-edge clinical-stage biotechnology firm, has received a significant green light from the U.S.
www.linkedin.com
January 24, 2025 at 9:39 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/fda-mf...

FDA and MFDS Approve ImmunoForge’s Leading Drugs for DMD and CML, Accelerating Clinical Trials

kstrategyand.com/pharma-news

#ImmunoForge #FDAApproval #Pemziviptadil #DMDCardiomyopathy #PharmaceuticalNews #FDA #MFDS #Humanteconomy #Humantec #KStrategyand
FDA and MFDS Approve ImmunoForge’s Leading Drugs for DMD and CML, Accelerating Clinical Trials
ImmunoForge, a pioneering biotech company, is making significant strides in the treatment of serious medical conditions with the recent approval of two Investigational New Drug (IND) applications by r...
www.linkedin.com
January 24, 2025 at 9:30 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/fda-gr...

FDA Greenlights Amgen’s Dual Therapy for KRAS G12C-Mutated Colorectal Cancer

kstrategyand.com/pharma-news

#FDAApproval #Amgen #Sotorasib #Panitumumab #ColorectalCancer #KRASG12C #CancerCare #HealthBreakthrough #Humanteconomy #Humantec #KStrategyand
FDA Greenlights Amgen’s Dual Therapy for KRAS G12C-Mutated Colorectal Cancer
On January 16, 2025, the U.S.
www.linkedin.com
January 24, 2025 at 9:17 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/cambri...

Cambridge and Cancer Research UK Unveil £10M AI-Powered Cancer Detection Programme

kstrategyand.com/pharma-news

#CancerResearch #AIinHealthcare #HealthTech #PersonalizedMedicine #NHSInnovation #HealthcareRevolution #AIForGood #Humanteconomy #Humantec #KStrategyand
Cambridge and Cancer Research UK Unveil £10M AI-Powered Cancer Detection Programme
In a groundbreaking effort to revolutionize cancer prevention and detection, Cambridge researchers are spearheading a £10 million initiative that promises to change how cancer is identified and manage...
www.linkedin.com
January 23, 2025 at 11:36 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/eli-li...

Eli Lilly Joins Forces with Scorpion Therapeutics in $2.5 Billion Cancer Drug Deal

kstrategyand.com/pharma-news

#EliLilly #ScorpionTherapeutics #MedicalInnovation #Healthcare #PharmaPartnerships #Verzenio #BiotechNews #Humanteconomy #Humantec #KStrategyand
Eli Lilly Joins Forces with Scorpion Therapeutics in $2.5 Billion Cancer Drug Deal
Eli Lilly and Co. is making waves in the oncology world with its bold move to acquire Scorpion Therapeutics' experimental PI3K inhibitor for a staggering $2.
www.linkedin.com
January 23, 2025 at 11:17 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/jp-mor...

JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025

kstrategyand.com/pharma-news

#HealthcareMergers #PharmaDeals #GSK #MergersAndAcquisitions #BiotechNews #Neuroscience #Oncology #Healthcare2025 #Humanteconomy #Humantec #KStrategyand
JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025
The financial hub of San Francisco buzzed with anticipation as the prestigious JP Morgan Healthcare Conference unfolded, setting the stage for a series of transformative announcements that could resha...
www.linkedin.com
January 23, 2025 at 11:09 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/fda-ap...

FDA Approves AstraZeneca and Daiichi Sankyo's Datopotamab Deruxtecan: A Breakthrough for Advanced Breast Cancer

kstrategyand.com/pharma-news

#FDAApproval #BreastCancerTreatment #DatopotamabDeruxtecan #MedicalAdvancements #Humanteconomy #Humantec #KStrategyand
FDA Approves AstraZeneca and Daiichi Sankyo's Datopotamab Deruxtecan: A Breakthrough for Advanced Breast Cancer
In a groundbreaking advancement for breast cancer treatment, the FDA has granted approval to datopotamab deruxtecan-dlnk, a Trop-2-directed antibody and topoisomerase inhibitor conjugate. Developed co...
www.linkedin.com
January 23, 2025 at 10:59 AM